Lisa van Velsen is a PhD candidate in the Department of Gastroenterology and Hepatology at Erasmus Medical Center, conducting research on the natural history and treatment outcomes of chronic hepatitis B virus (HBV) infection.

Thanh Kim, MD, is a practicing gastroenterologist and physician-epidemiologist from Viet Nam whose work focuses on improving the prevention, detection, and management of chronic liver disease, particularly hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). He practices gastroenterology at An Binh Hospital and serves as a faculty member at Pham Ngoc Thach University of Medicine in Ho Chi Minh City, where his work spans clinical care, medical education, and research.

Erin M. Mann, PhD, MPH, is a researcher in the Division of Infectious Diseases and International Medicine at the University of Minnesota. She holds a PhD in Epidemiology from the University of Minnesota School of Public Health and an MPH from Boston University. Her research focuses on viral hepatitis and liver cancer in global and migrant populations, including hepatitis B screening, vaccination, and linkage to care among refugees resettling to the United States.

Consultant Hepatologist at Egyptian Liver Research Institute and Hospital. I hold a PhD in Gastroenterology and Hepatology and am also a Lecturer in Gastroenterology and Hepatology Medicine. My research focuses particularly on HCC prediction and personalised surveillance, hepatitis elimination, non-invasive assessment of liver disease and innovative diagnostics for hepatitis C. I have led community-based hepatitis elimination initiatives, including the Educate, Test & Treat programme, and have contributed to numerous international publications and clinical trials.

Federico García, PhD, is Head of the Microbiology Department at the University Hospital San Cecilio, Granada, Spain and Associate Professor in Microbiology at the University of Granada.
His current research activities include hepatitis B, C and delta virus, transmitted drug resistance in Spain and Europe, and clinical significance of HIV low- and very low-level viraemia.

Dr Rex Wan-Hin Hui is a clinician-scientist in The University of Hong Kong. He received his medical degree in 2018, graduating at the top of his class with the John Anderson Gold Medal. He completed his Hepatology specialty training and also completed his PhD in 2025.

Dr Hui's research focuses on risk prediction in hepatocellular carcinoma and hepatitis B. He has published over 75 articles, including articles in the Journal of Hepatology, Gut, Hepatology, and Clinical & Molecular Hepatology as lead author.

Physician scientist at Medical University of Vienna, Austria